TYW3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.896000E-01
Normal-vs-Stage2
2.818600E-01
Normal-vs-Stage3
7.705900E-02
Normal-vs-Stage4
3.393000E-01
Stage1-vs-Stage2
4.753900E-02
Stage1-vs-Stage3
2.758000E-02
Stage1-vs-Stage4
4.108800E-01
Stage2-vs-Stage3
1.574020E-01
Stage2-vs-Stage4
7.281600E-03
Stage3-vs-Stage4
6.423100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.935600E-01
Normal-vs-AfricanAmerican
8.550600E-01
Normal-vs-Asian
6.162400E-02
Caucasian-vs-AfricanAmerican
3.947400E-01
Caucasian-vs-Asian
3.758400E-02
AfricanAmerican-vs-Asian
4.932100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.190200E-01
Normal-vs-Female
4.659000E-01
Male-vs-Female
3.910200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.843800E-01
Normal-vs-Age(41-60Yrs)
6.818200E-01
Normal-vs-Age(61-80Yrs)
2.702200E-01
Normal-vs-Age(81-100Yrs)
2.193800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.440800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.766800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.144000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.669880E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.328200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.160400E-02
Normal-vs-Daily Drinker
1.251390E-01
Normal-vs-Weekly Drinker
2.378300E-02
Normal-vs-Occasional Drinker
6.657000E-01
Normal-vs-Social Drinker
9.570600E-01
Non Drinker-vs-Daily Drinker
4.642400E-01
Non Drinker-vs-Weekly Drinker
2.273600E-01
Non Drinker-vs-Occasional Drinker
4.398200E-03
Non Drinker-vs-Social Drinker
3.732500E-02
Daily Drinker-vs-Weekly Drinker
7.179600E-02
Daily Drinker-vs-Occasional Drinker
2.930200E-02
Daily Drinker-vs-Social Drinker
8.651900E-02
Weekly Drinker-vs-Occasional Drinker
6.351600E-04
Weekly Drinker-vs-Social Drinker
8.661600E-03
Occasional Drinker-vs-Social Drinker
6.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.692200E-02
Normal-vs-Grade 2
2.017500E-03
Normal-vs-Grade 3
5.104800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.979800E-01
Grade 1-vs-Grade 3
7.465800E-01
Grade 1-vs-Grade 4
2.692200E-02
Grade 2-vs-Grade 3
6.290600E-01
Grade 2-vs-Grade 4
2.017500E-03
Grade 3-vs-Grade 4
5.104800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.159800E-01
Normal-vs-NonDiabetic
3.065400E-01
Diabetic-vs-NonDiabetic
5.086600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.080760E-01
Normal-vs-NoPancreatitis
3.184200E-01
Pancreatitis-vs-NoPancreatitis
3.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.740800E-01
Normal-vs-N1
2.757000E-01
N0-vs-N1
3.816200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.642800E-01
Normal-vs-TP53-NonMutant
8.344200E-01
TP53-Mutant-vs-TP53-NonMutant
3.275200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
